A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia
PHASE3
This is a multicenter, multinational, open-label, one-way cross-over, Phase...
Status
Active Not Recruiting
Location
Center for Inherited Blood Disorders (CIBD) Site Number : 8400012
A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment
N/A
This non-interventional study will prospectively collect detailed, high-qua...
A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
PHASE4
This is an exploratory, single group, Phase 4, study to assess treatment wi...
Status
Recruiting
Location
Children's Hospital Los Angeles- Site Number : 8400005
Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors
N/A
Background
The treatment of haemophilia A and B has been revolutionized by...
Status
Recruiting
Location
Karolinska University Hospital
Start Date
2015-03-01
Trial ID
NCT02453542
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors
PHASE3
This multicenter, open-label study will evaluate the safety, efficacy and p...